Literature DB >> 29499626

Resilience as a moderator between syndemics and depression in mothers living with HIV.

Idia B Thurston1,2, Kathryn H Howell1, Rebecca C Kamody1, Courtney Maclin-Akinyemi1, Jessica Mandell1.   

Abstract

Physical and emotional adversities in mothers have rippling effects across the family system. While an association between individual maternal adversities and problematic mental health outcomes has been established, less is known about co-existing adversities in mothers. Consistent with the syndemic conceptual framework, we examined the co-occurrence of Substance Abuse, Violence, and AIDS/HIV (i.e., SAVA), which are three adversities that uniquely affect racial/ethnic minorities, individuals living in poverty, and people in urban communities. We assessed the relationship between SAVA adversities and depressive symptoms among mothers living with HIV, as well as the moderating effect of resilience on this relationship. Participants included 55 mothers (Mage = 41.24, SD = 9.01; 81% Black) living with HIV in the U.S. MidSouth. Mothers were recruited from community agencies serving individuals living with HIV and completed hour-long interviews about SAVA, depression, resilience, life stressors, and their child's mental health. Analyses were conducted in PROCESS for SPSS to test the relationship between SAVA and depression, as moderated by resilience. Analyses controlled for the influence of child maladaptive functioning (given known associations with maternal mental health) and maternal life stressors (given established associations with depressive symptoms). Findings indicated that experiencing more than one SAVA variable was associated with greater depressive symptoms (p < .05). Higher resilience was associated with lower depressive symptoms (r = -.45; p < .01). Moderation was supported (β = -.80; p < .01) as the relationship between more SAVA epidemics and higher depressive symptoms was stronger when resilience was low and weaker when resilience was high. Results not only highlight how co-occurring adversities exacerbate depressive symptoms, but also underscore the role of resilience as a key protective factor among mothers living with HIV. Resilience could therefore be a target of strengths-based treatment to reduce the negative effects of SAVA on depressive symptoms among mothers.

Entities:  

Keywords:  AIDS; Domestic violence; resilient functioning; substance use; women

Mesh:

Year:  2018        PMID: 29499626     DOI: 10.1080/09540121.2018.1446071

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  10 in total

1.  Stress, Resilience, and Cardiovascular Disease Risk Among Black Women.

Authors:  Ashley S Felix; Amy Lehman; Timiya S Nolan; Shawnita Sealy-Jefferson; Khadijah Breathett; Darryl B Hood; Daniel Addison; Cindy M Anderson; Crystal W Cené; Barbara J Warren; Rebecca D Jackson; Karen Patricia Williams
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2019-04

2.  Distress screening in endometrial cancer leads to disparity in referral to support services.

Authors:  Hadley W Reid; Gloria Broadwater; Mary Katherine Montes de Oca; Bharathi Selvan; Oluwadamilola Fayanju; Laura J Havrilesky; Brittany A Davidson
Journal:  Gynecol Oncol       Date:  2022-01-10       Impact factor: 5.482

3.  Black Women Living with HIV: A Latent Profile Analysis of Intersectional Adversities, Resilience, and Mental Health.

Authors:  Devina J Boga; Sannisha K Dale
Journal:  AIDS Patient Care STDS       Date:  2022-08-30       Impact factor: 5.944

4.  Exploring Resilience Among Black Women Living With HIV in the Southern United States: Findings From a Qualitative Study.

Authors:  Amie Koch; Tiarney D Ritchwood; Donald E Bailey; Courtney Ellis Caiola; Adaora A Adimora; Catalina Ramirez; Lauren Holt; Ragan Johnson; Kara McGee; Jacquelyn M McMillian-Bohler; Schenita D Randolph; Michael V Relf
Journal:  J Assoc Nurses AIDS Care       Date:  2022 Mar-Apr 01       Impact factor: 1.809

5.  Sociodemographic and psychosocial correlates of resilience among older adults living with HIV in the Deep South.

Authors:  Monique J Brown; J Stewart Trask; Jiajia Zhang; Mohammad Rifat Haider; Xiaoming Li
Journal:  J Health Psychol       Date:  2020-01-08

6.  The People Living with HIV (PLHIV) Resilience Scale: Development and Validation in Three Countries in the Context of the PLHIV Stigma Index.

Authors:  A Gottert; B Friedland; S Geibel; L Nyblade; S D Baral; S Kentutsi; C Mallouris; L Sprague; J Hows; F Anam; U Amanyeiwe; J Pulerwitz
Journal:  AIDS Behav       Date:  2019-09

7.  Examining Multilevel Factors Associated with the Process of Resilience among Women Living with HIV in a Large Canadian Cohort Study: A Structural Equation Modeling Approach.

Authors:  Roula Kteily-Hawa; Laura Warren; Mina Kazemi; Carmen H Logie; Shazia Islam; Angela Kaida; Tracey Conway; Yasmeen Persad; Alexandra de Pokomandy; Mona Loutfy
Journal:  J Int Assoc Provid AIDS Care       Date:  2019 Jan-Dec

8.  The Intersection of Alcohol Use, Gender Based Violence and HIV: Empirical Findings among Disadvantaged Service-Seeking Youth in Kampala, Uganda.

Authors:  Monica H Swahn; Rachel Culbreth; Katherine E Masyn; Laura F Salazar; Jennifer Wagman; Rogers Kasirye
Journal:  AIDS Behav       Date:  2021-05-14

9.  HIV, psychological resilience, and substance misuse during the COVID-19 pandemic: A multi-cohort study.

Authors:  Marianna K Baum; Javier A Tamargo; Janet Diaz-Martinez; Ivan Delgado-Enciso; Christina S Meade; Gregory D Kirk; Shruti H Mehta; Richard Moore; Michele D Kipke; Steven J Shoptaw; Brian Mustanski; Raul N Mandler; Jag H Khalsa; Suzanne Siminski; Marjan Javanbakht; Pamina M Gorbach
Journal:  Drug Alcohol Depend       Date:  2021-12-24       Impact factor: 4.852

10.  Patient-reported causes of distress predict disparities in time to evaluation and time to treatment after breast cancer diagnosis.

Authors:  Oluwadamilola M Fayanju; Yi Ren; Ilona Stashko; Steve Power; Madeline J Thornton; P Kelly Marcom; Terry Hyslop; E Shelley Hwang
Journal:  Cancer       Date:  2020-11-11       Impact factor: 6.860

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.